Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tissucol Duo for Lymphocele Prevention in Gynaecological Cancer
NCT03914963Phase 3Completed
- Start
- Feb 2012
- Primary completion
- Jun 2016
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, double-blind trial of tisseel in lymphocele. Primary endpoint: Incidence of Lymphocele at 12 months. Started Feb 2012; status: completed.
02
Drugs
tisseel
03
Conditions
lymphocele
Beyond the preview
Go deeper on NCT03914963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03914963.